Anika Therapeutics (ANIK) Goodwill & Intangibles (2016 - 2026)
Anika Therapeutics has reported Goodwill & Intangibles over the past 17 years, most recently at $9.6 million for Q1 2026.
- Quarterly Goodwill & Intangibles rose 5.14% to $9.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $9.6 million through Mar 2026, up 5.14% year-over-year, with the annual reading at $9.7 million for FY2025, 64.01% down from the prior year.
- Goodwill & Intangibles was $9.6 million for Q1 2026 at Anika Therapeutics, down from $9.7 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $119.5 million in Q4 2022 and troughed at $8.3 million in Q3 2024.
- The 5-year median for Goodwill & Intangibles is $57.3 million (2024), against an average of $51.5 million.
- The largest YoY upside for Goodwill & Intangibles was 165.7% in 2024 against a maximum downside of 93.08% in 2024.
- A 5-year view of Goodwill & Intangibles shows it stood at $119.5 million in 2022, then tumbled by 91.51% to $10.1 million in 2023, then soared by 165.7% to $27.0 million in 2024, then crashed by 64.01% to $9.7 million in 2025, then decreased by 1.15% to $9.6 million in 2026.
- Per Business Quant, the three most recent readings for ANIK's Goodwill & Intangibles are $9.6 million (Q1 2026), $9.7 million (Q4 2025), and $9.7 million (Q3 2025).